SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-19-000089
Filing Date
2019-08-07
Accepted
2019-08-07 16:31:07
Documents
102
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2019063010qdoc.htm 10-Q 2249126
2 SETTLEMENT LETTER AND SUPPLY AGREEMENT AMENDMENT pdli-2019063010qex104.htm EX-10.4 52857
3 CERTIFICATION pdli-2019063010qex311.htm EX-31.1 10978
4 CERTIFICATION pdli-2019063010qex312.htm EX-31.2 11262
5 CERTIFICATION pdli-2019063010qex321.htm EX-32.1 14291
12 pdllogoa22.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000089.txt   12797713

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20190630.xml EX-101.INS 2728803
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20190630.xsd EX-101.SCH 112210
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20190630_cal.xml EX-101.CAL 126348
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20190630_def.xml EX-101.DEF 697027
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20190630_lab.xml EX-101.LAB 1132355
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20190630_pre.xml EX-101.PRE 867233
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 191005916
SIC: 2836 Biological Products, (No Diagnostic Substances)